Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
Bausch Health
BHC
$2.58B
| $400K | ﹤0.01% |
12,600
-1,200
| -9% | -$35.2K |
|
3277
International Seaways
INSW
$4.76B
| $399K | ﹤0.01% |
20,588
+12,836
| +166% | +$238K |
|
3278
Regis Corp
RGS
$68.4M
| $399K | ﹤0.01% |
1,585
+252
| +19% | +$55.1K |
|
3279
PUT
Bristol-Myers Squibb
BMY
$133B
| $398K | ﹤0.01% |
6,300
-417,000
| -99% | -$25.9M |
|
3280
Shore Bancshares
SHBI
$819M
| $398K | ﹤0.01% |
23,373
+4,092
| +21% | +$63K |
|
|
PLYM
3281
DELISTED
Plymouth Industrial REIT
PLYM
| $397K | ﹤0.01% |
23,611
+10,202
| +76% | +$159K |
|
3282
BlackRock Enhanced Global Dividend Trust
BOE
$673M
| $396K | ﹤0.01% |
+31,365
| New | +$348K |
|
3283
Icon
ICLR
$12.6B
| $396K | ﹤0.01% |
2,014
-1,735
| -46% | -$343K |
|
3284
Esquire Financial Holdings
ESQ
$1.12B
| $395K | ﹤0.01% |
17,292
+3,550
| +26% | +$81.7K |
|
3285
PUT
Las Vegas Sands
LVS
$31.7B
| $395K | ﹤0.01% |
6,500
-34,500
| -84% | -$2.02M |
|
3286
RBB Bancorp
RBB
$448M
| $395K | ﹤0.01% |
19,478
+7,713
| +66% | +$147K |
|
3287
Digimarc Corp
DMRC
$147M
| $394K | ﹤0.01% |
13,293
+9,434
| +244% | +$374K |
|
3288
Bank First Corp
BFC
$1.69B
| $393K | ﹤0.01% |
5,246
+3,221
| +159% | +$227K |
|
|
CARM
3289
DELISTED
Carisma Therapeutics
CARM
| $392K | ﹤0.01% |
+7,532
| New | +$355K |
|
3290
PUT
Eli Lilly
LLY
$1.02T
| $392K | ﹤0.01% |
2,100
-196,300
| -99% | -$38.4M |
|
3291
UroGen Pharma
URGN
$1.86B
| $392K | ﹤0.01% |
20,068
+9,490
| +90% | +$201K |
|
|
AMRN
3292
Amarin Corp
AMRN
$299M
| $391K | ﹤0.01% |
3,148
+1,162
| +59% | +$156K |
|
3293
UFP Technologies
UFPT
$1.97B
| $391K | ﹤0.01% |
7,851
+5,635
| +254% | +$275K |
|
3294
Investar Holding Corp
ISTR
$415M
| $390K | ﹤0.01% |
18,965
+7,331
| +63% | +$138K |
|
3295
Business First Bancshares
BFST
$1.04B
| $389K | ﹤0.01% |
16,243
+10,018
| +161% | +$223K |
|
3296
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
| $389K | ﹤0.01% |
+11,898
| New | +$369K |
|
3297
iBio
IBIO
$69.5M
| $389K | ﹤0.01% |
506
+390
| +336% | +$340K |
|
3298
Crane NXT
CXT
$2.99B
| $388K | ﹤0.01% |
11,882
+769
| +7% | +$22.8K |
|
3299
RPC Inc
RES
$1.24B
| $388K | ﹤0.01% |
72,023
-75,932
| -51% | -$385K |
|
|
LTRPA
3300
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $388K | ﹤0.01% |
60,773
+37,308
| +159% | +$202K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.